DSIJ Mindshare

230 per cent returns: This multibagger pharmaceutical company announced approval for a new drug from US FDA; do you own it?

The company has delivered returns of 14.5 per cent over the past 3 years and returns of 230 per cent over the past 5 years.

Siddharth Mane 0 14408 Article rating: 4.1

The company has a ROCE of 19.4 per cent and a ROE of 19.1 per cent.

Overnight Digest: Stocks likely to be in focus on August 1

Keep an eye on these stocks for Monday's trading session

Shreya Chaware 0 4570 Article rating: 4.4

On Friday, investors piled up the metal and IT shares, coupled with some major Sensex stocks like Reliance Industries, HDFC twins, Sun Pharma, and Bajaj Finance. The benchmark indices ended the trading session near the day's high level, closing the week on a green note. 

Stocks to watch: These smallcap stocks will be in focus tomorrow!

Nahar Capital and Financial Services, Sree Rayalaseema Hi-Strength Hypo, Linde India, Excel Industries, Kothari Products, Nahar Poly Films, Polyplex Corporation and Supreme Petrochem made a fresh 52-week high today.  

Armaan Madhani 0 1083 Article rating: 4.4

BSE Smallcap index outperformed broader markets, losing only 0.88 per cent and closing at 26,987.85.

RSS
DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR